Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2025-12-25 @ 4:33 AM
NCT ID:
NCT02659618
Eligibility Criteria:
Inclusion Criteria:
* Physician diagnosis of severe persistent asthma;
* Positive skin test or radioallergosorbent test (RAST) for an aeroallergen;
* Male or female age 12-65 years;
* Non-smoker.
Exclusion Criteria:
* Asthma exacerbation requiring treatment with or increase in oral corticosteroids within 30 days prior to the study;
* Respiratory infection within 30 days prior to the study;
* Starting or requiring a change in allergen immunotherapy within 30 days prior to the study;
* Having been treated with Xolair within the past year;
* Requiring chronic immunosuppressive therapy;
* Having taken methotrexate, gold salts, cyclosporine, or macrolide antibiotics within 3 months prior to study;
* Having taken an investigational drug within 30 days prior to the study;
* Have a history of drug or alcohol abuse;
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
65 Years
Study:
NCT02659618
Study Brief:
Protocol Section:
NCT02659618